Adverum Biotechnologies
ADVM
ADVM
99 hedge funds and large institutions have $267M invested in Adverum Biotechnologies in 2019 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 35 increasing their positions, 21 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
0.33% more ownership
Funds ownership: 7.27% → 7.6% (+0.33%)
51% less capital invested
Capital invested by funds: $549M → $267M (-$282M)
100% less funds holding in top 10
Funds holding in top 10: 3 → 0 (-3)
Holders
99
Holding in Top 10
–
Calls
$7.25M
Puts
$6.68M
Top Buyers
| 1 | +$18.1M | |
| 2 | +$11.2M | |
| 3 | +$7.9M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$4.48M |
| 5 |
ACA
Avoro Capital Advisors
New York
|
+$4.09M |
Top Sellers
| 1 | -$14.1M | |
| 2 | -$10.9M | |
| 3 | -$8.98M | |
| 4 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$8.56M |
| 5 |
PC
Polar Capital
London,
United Kingdom
|
-$7.45M |